s*****n
发帖数: 2858 | |
r*****e
发帖数: 7853 | 2 注意什么？
【在 s*****n 的大作中提到】
: 注意
|
t*********e
发帖数: 540 | |
n*******s
发帖数: 17267 | |
N*****d
发帖数: 9872 | |
b******9
发帖数: 2706 | 6 明天估计破68没啥问题了。HIV新药数据全面好于GSK的。但是指望从此大涨是不可能的。
The study numbers, finally released Monday night, did not disappoint. After
24 and 48 weeks of treatment with a combination regimen of bictegravir and
Gilead's TAF-based backbone, 97% of newly diagnosed HIV patients had
suppressed HIV viral loads considered undetectable.
By comparison, 94% of patients in the study treated with Glaxo's
dolutegravir and Gilead's TAF backbone for 24 weeks reached undetectable HIV
suppression. At 48 weeks, full viral suppression in these patients fell to
91%.
The safety profile of both drugs was relatively similar, although
bictegravir performed slightly better than dolutegravir on a measure of
kidney function. |
s*****n
发帖数: 2858 | 7 今天关键了。
【在 s*****n 的大作中提到】
: 注意
|
s*****n
发帖数: 2858 | |
r*****e
发帖数: 7853 | 9 牛x
[在 soupman (Soupman returns!) 的大作中提到：]
:我提这个68还是很有道理的。 |
r*****e
发帖数: 7853 | 10 GILD是货真价实的买卖，昨天一个HIV的ppt没起作用
我反正不亏了，let it run。心里还惦记着大夫的1500未必 |
b******9
发帖数: 2706 | 11 明天或者下星期就破了，然后回去补钙？
[在 soupman (Soupman returns!) 的大作中提到：]
:我提这个68还是很有道理的。 |
